Open Label, Phase I ZD6474 Head and Neck Cancer Study
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the maximum tolerated dose of ZD6474 given in
combination with radiation or in combination with chemotherapy and radiation in patients with
squamous cell carcinoma of the head and neck.